Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein
- 31 December 1993
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 29 (3), 408-415
- https://doi.org/10.1016/0959-8049(93)90397-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitroBritish Journal of Cancer, 1992
- Cyclosporins as drug resistance modifiersBiochemical Pharmacology, 1992
- Combinedin vitro modulation of adriamycin resistanceInternational Journal of Cancer, 1991
- Retention of activity by selected anthracyclines in a multidrug resistant human large cell lung carcinoma line without P-glycoprotein hyperexpressionBritish Journal of Cancer, 1991
- Non-P-glycoprotein-mediated multidrug resistance with reduced EGF receptor expression in a human large cell lung cancer cell lineBritish Journal of Cancer, 1990
- P‐glycoprotein: multidrug‐resistance and a superfamily of membrane‐associated transport proteinsThe FASEB Journal, 1989
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989
- Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoproteinBritish Journal of Cancer, 1989
- Adriamycin resistance in HL60 cells in the absence of detectable P-glycoproteinBiochemical and Biophysical Research Communications, 1987
- Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cellsBritish Journal of Cancer, 1986